JNJ-64140284

· Janssen Pharmaceutica N.V.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for JNJ-64140284, covering 2025-04-27 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-64140284 in Healthy Male Participants [Phase 1]